Ads
related to: thrombotic thrombocytopenic purpura nhs- Doptelet Clinical Trials
Learn More About How This Treatment
Performed In Clinical Studies.
- Official Patient Website
Visit Patient Website For More
Information On Doptelet.
- Doptelet FAQ's
Learn More About Some Frequently
Asked Questions About Doptelet.
- Watch Our Videos
Learn More About Treatment For
Doptelet Through Video Library.
- Get Doptelet Updates
Sign Up To Get Info On Doptelet To
Help Patients Set Treatment Goals.
- Access & Resources
Download Doptelet Access And
Enrollment Forms For Information.
- Doptelet Clinical Trials
Search results
Results From The WOW.Com Content Network
Thrombotic thrombocytopenic purpura (TTP) is a blood disorder that results in blood clots forming in small blood vessels throughout the body. [2] This results in a low platelet count , low red blood cells due to their breakdown , and often kidney , heart , and brain dysfunction. [ 1 ]
Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia accompanied by variable neurological dysfunction, kidney failure, and fever. It is caused by severely reduced activity of the von Willebrand factor-cleaving protease ADAMTS13.
By tradition, the term idiopathic thrombocytopenic purpura is used when the cause is idiopathic, or unknown. However, most cases are now considered to be immune-mediated. [citation needed] Another form is thrombotic thrombocytopenic purpura. [citation needed]
Thrombotic thrombocytopenic purpura (TTP), a TMA, was first described by the Hungarian born, American pathologist and physician Eli Moschcowitz (1879–1964). In 1924, [ 51 ] Moschcowitz first described TTP as a distinct clinicopathologic condition that can mimic the clinical characteristics of Hemolytic–uremic syndrome (HUS).
Oral petechiae/purpura - immune thrombocytopenic purpura. Many cases of immune thrombocytopenic purpura (ITP), also known as idiopathic thrombocytopenic purpura, can be left untreated, and spontaneous remission (especially in children) is not uncommon. However, counts under 50,000/μL are usually monitored with regular blood tests, and those ...
Liver disease, HELLP syndrome, thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, and malignant hypertension may mimic DIC but originate via other pathways. [9] It is not the same as conditions where the blood vessels leak, such as capillary leak syndrome. [10]
Ads
related to: thrombotic thrombocytopenic purpura nhs